Brief: Intelligent Bio Solutions Provides Updated Timeline For Anticipated FDA 510(K) Submission And Clearance
26/09/2025 13:51
Sept 26 (Reuters) - Intelligent Bio Solutions Inc INBS.O: INTELLIGENT BIO SOLUTIONS ADVANCES PREPARATIONS AND PROVIDES UPDATED TIMELINE FOR ANTICIPATED FDA 510(K) SUBMISSION AND CLEARANCE INTELLIGENT BIO SOLUTIONS INC - ANTICIPATES FDA 510(K) CLEARANCE IN SECOND HALF OF 2026 Source text: ID:nGNX8dcdLq Further company coverage: INBS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelligent Bio Solutions
See all newsBrief: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth
Brief: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50%
Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing
Brief: Intelligent Bio Solutions Completes Clinical Cut-Off Study